大剂量阿昔洛韦持续输注用于严重疱疹病毒感染。
Continuous infusion of high-dose acyclovir for serious herpesvirus infections.
作者信息
Fletcher C V, Englund J A, Bean B, Chinnock B, Brundage D M, Balfour H H
机构信息
Department of Pharmacy Practice, University of Minnesota, Health Sciences Center, Minneapolis 55455.
出版信息
Antimicrob Agents Chemother. 1989 Aug;33(8):1375-8. doi: 10.1128/AAC.33.8.1375.
Abstract
Thirteen patients with herpesvirus infections who were unresponsive to at least 72 h of intermittent acyclovir administration received high-dose continuous infusion. Steady-state concentrations were maintained at between 20 and 98 mumol/liter. Of 12 patients who had continuous infusion for greater than 5 days, 7 (58%) resolved their infections, as determined by clinical and virologic parameters, suggesting that continuous infusion may succeed in some patients who do not respond to conventional therapy.
摘要
13名对阿昔洛韦间歇给药至少72小时无反应的疱疹病毒感染患者接受了大剂量持续输注。稳态浓度维持在20至98微摩尔/升之间。在12名接受持续输注超过5天的患者中，根据临床和病毒学参数判定，7名（58%）患者的感染得到解决，这表明持续输注可能对某些对传统治疗无反应的患者有效。
相似文献
1
Continuous infusion of high-dose acyclovir for serious herpesvirus infections.大剂量阿昔洛韦持续输注用于严重疱疹病毒感染。
Antimicrob Agents Chemother. 1989 Aug;33(8):1375-8. doi: 10.1128/AAC.33.8.1375.
2
Intravenous acyclovir for herpesvirus in immunocompromised patients.免疫功能低下患者静脉注射阿昔洛韦治疗疱疹病毒感染
Isr J Med Sci. 1985 Jan;21(1):27-31.
3
High-dose oral acyclovir for children at risk of disseminated herpesvirus infections.高剂量口服阿昔洛韦用于有播散性疱疹病毒感染风险的儿童。
J Infect Dis. 1985 Feb;151(2):372. doi: 10.1093/infdis/151.2.372.
4
[Acyclovir therapy of herpesvirus infections in childhood].[阿昔洛韦治疗儿童疱疹病毒感染]
Minerva Pediatr. 1986 Apr 30;38(8):289-92.
5
[Acyclovir (Zovirax) in the treatment of Herpesvirus infections in children with neoplasms].[阿昔洛韦（无环鸟苷）治疗肿瘤患儿的疱疹病毒感染]
Pol Tyg Lek. 1984 May 28;39(22):755-7.
6
Acyclovir in the treatment of infection due to herpes viruses.阿昔洛韦治疗疱疹病毒感染。
Czech Med. 1986;9(4):203-5.
7
Pharmacokinetics of acyclovir suspension in infants and children.阿昔洛韦混悬液在婴幼儿中的药代动力学。
Antimicrob Agents Chemother. 1987 Nov;31(11):1722-6. doi: 10.1128/AAC.31.11.1722.
8
[Drug therapy of intractable virus diseases].
Nihon Naika Gakkai Zasshi. 1990 Dec 10;79(12):1685-8.
9
[Acyclovir in the therapy of herpesvirus infections].[阿昔洛韦在疱疹病毒感染治疗中的应用]
Schweiz Med Wochenschr. 1984 Jan 7;114(1):14-5.
10
Acyclovir in accelerated phase of Chediak-Higashi syndrome.阿昔洛韦用于切-希二氏综合征加速期。
Lancet. 1987 Jan 24;1(8526):212-3. doi: 10.1016/s0140-6736(87)90020-1.
引用本文的文献
1
Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients.静脉注射阿昔洛韦在儿科肿瘤患者中的群体药代动力学
Front Pharmacol. 2022 Apr 14;13:865871. doi: 10.3389/fphar.2022.865871. eCollection 2022.
2
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.儿科传染病与免疫学中的药代动力学/药效学建模方法
Adv Drug Deliv Rev. 2014 Jun;73(100):127-39. doi: 10.1016/j.addr.2014.01.002. Epub 2014 Jan 17.
3
Famciclovir for the management of genital herpes simplex in patients with inadequate response to aciclovir or valaciclovir.泛昔洛韦用于对阿昔洛韦或伐昔洛韦反应欠佳的生殖器单纯疱疹患者的治疗。
Clin Drug Investig. 2005;25(12):803-9. doi: 10.2165/00044011-200525120-00006.
4
Drug treatment of HIV-related opportunistic infections.艾滋病相关机会性感染的药物治疗。
Drugs. 1997 Jan;53(1):40-73. doi: 10.2165/00003495-199753010-00004.
5
Continuous infusion of acyclovir is more effective than discontinuous infusion for treatment of genital herpes in an immunocompromised patient.
Infection. 1994 Jul-Aug;22(4):290. doi: 10.1007/BF01739921.
6
Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.阿昔洛韦。对其抗病毒活性、药代动力学特性及治疗效果的重新评估。
Drugs. 1994 Jan;47(1):153-205. doi: 10.2165/00003495-199447010-00009.
本文引用的文献
1
Overview of acyclovir pharmacokinetic disposition in adults and children.阿昔洛韦在成人和儿童体内的药代动力学处置概述。
Am J Med. 1982 Jul 20;73(1A):186-92. doi: 10.1016/0002-9343(82)90088-2.
2
Virus resistance in clinical practice.临床实践中的病毒抗性
J Antimicrob Chemother. 1983 Sep;12 Suppl B:137-52. doi: 10.1093/jac/12.suppl_b.137.
3
Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion.
Am J Med. 1982 Jul 20;73(1A):275-80. doi: 10.1016/0002-9343(82)90105-x.
4
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.肾移植后爱泼斯坦-巴尔病毒诱导的B细胞淋巴瘤：阿昔洛韦治疗及从多克隆B细胞增殖向单克隆B细胞增殖的转变
N Engl J Med. 1982 Apr 15;306(15):913-8. doi: 10.1056/NEJM198204153061506.
5
Neurotoxicity due to adenine arabinoside therapy during varicella-zoster virus infections in immunocompromised children.免疫功能低下儿童水痘-带状疱疹病毒感染期间，阿糖腺苷治疗导致的神经毒性。
J Infect Dis. 1986 Nov;154(5):889-93. doi: 10.1093/infdis/154.5.889.
6
7
Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS.一名艾滋病患者因感染对阿昔洛韦耐药的病毒而引发严重的进行性疱疹性瘭疽。
J Infect Dis. 1988 Jan;157(1):209-10. doi: 10.1093/infdis/157.1.209.
8
Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy.
Diagn Microbiol Infect Dis. 1987 Jul;7(3):199-204. doi: 10.1016/0732-8893(87)90005-8.
9
Prediction of creatinine clearance from serum creatinine.根据血清肌酐预测肌酐清除率。
Nephron. 1976;16(1):31-41. doi: 10.1159/000180580.
10
A program package for simulation and parameter estimation in pharmacokinetic systems.一个用于药代动力学系统模拟和参数估计的程序包。
Comput Programs Biomed. 1979 Mar;9(2):115-34. doi: 10.1016/0010-468x(79)90025-4.
Zotero 插件